Emergence of RAS mutations in patients with metastatic colorectal cancer receiving cetuximab-based treatment

被引：0
|
作者：
Wang, Jaw-Yuan
Tsai, Hsiang-Lin
Sung, Yung-Chuan
机构：
[1] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan
[2] Kaohsiung Med Univ, Chung Ho Mem Hosp, Dept Surg, Div Colorectal Surg, Kaohsiung, Taiwan
[3] Cathay Gen Hosp, Div Hematol Oncol, Dept Internal Med, Taipei, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
208
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Emergence of RAS mutations in patients with metastatic colorectal cancer receiving cetuximab-based treatment: a study protocol
    Shang-Hung Chen
    Hsiang-Lin Tsai
    Jeng-Kai Jiang
    Yung-Chuan Sung
    Ching-Wen Huang
    Yu-Min Yeh
    Li-Tzong Chen
    Jaw-Yuan Wang
    BMC Cancer, 19
  • [2] Emergence of RAS mutations in patients with metastatic colorectal cancer receiving cetuximab-based treatment: a study protocol
    Chen, Shang-Hung
    Tsai, Hsiang-Lin
    Jiang, Jeng-Kai
    Sung, Yung-Chuan
    Huang, Ching-Wen
    Yeh, Yu-Min
    Chen, Li-Tzong
    Wang, Jaw-Yuan
    BMC CANCER, 2019, 19 (1)
  • [3] Emergence of RAS mutations in RAS wild type metastatic colorectal cancer patients receiving cetuximab as first-line treatment: A prospective study.
    Tsai, Hsiang-Lin
    Wang, Jaw-Yuan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 38 - 38
  • [4] ADCC and treatment outcome in colorectal cancer patients receiving cetuximab-based therapy
    Milano, Gerard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [5] Cetuximab-based therapy for metastatic colorectal cancer: a meta-analysis of the effect of K-ras mutations
    Ibrahim, Ezzeldin M.
    Zekri, Jamal M.
    Bin Sadiq, Bakr M.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2010, 25 (06) : 713 - 721
  • [6] Cetuximab-based therapy for metastatic colorectal cancer: a meta-analysis of the effect of K-ras mutations
    Ezzeldin M. Ibrahim
    Jamal M. Zekri
    Bakr M. Bin Sadiq
    International Journal of Colorectal Disease, 2010, 25 : 713 - 721
  • [7] Detection of RAS gene mutations in patients with metastatic colorectal cancer during cetuximab-based first-line treatment and survival of the patients in relation to changes in RAS gene status
    Stresko, M.
    Behulova, R.
    Sebest, L.
    Valencikova, R.
    Plancikova, D.
    Melichova, J.
    Usakova, V.
    Dienerova, M.
    Grmanova, E.
    Vaclav, V.
    Drahokoupilova, M.
    Novisedlakova, M.
    Fremal, M.
    Puskarova, B.
    Szegheova, O.
    Rosinska, O.
    Detvay, J.
    Durkova, J.
    Pindesova, L.
    Gura, R.
    Racayova, Z.
    Chmelkova, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S63 - S63
  • [8] Cetuximab-based therapy in elderly comorbid patients with metastatic colorectal cancer
    Jehn, C. F.
    Boening, L.
    Kroening, H.
    Possinger, K.
    Lueftner, D.
    BRITISH JOURNAL OF CANCER, 2012, 106 (02) : 274 - 278
  • [9] Cetuximab-based therapy in elderly comorbid patients with metastatic colorectal cancer
    C F Jehn
    L Böning
    H Kröning
    K Possinger
    D Lüftner
    British Journal of Cancer, 2012, 106 : 274 - 278
  • [10] Italian survey on cetuximab-based therapy of elderly patients with metastatic colorectal cancer
    Gerardo Rosati
    Raffaele Addeo
    Giuseppe Aprile
    Antonio Avallone
    Domenico Bilancia
    Silvia Brugnatelli
    Gabriella Buccafusca
    Chiara Carlomagno
    Stefano Cordio
    Sara Delfanti
    Emanuela Dell’Aquila
    Maurizio Di Bisceglie
    Samantha Di Donato
    Antonio Di Stasi
    Domenico Germano
    Francesco Giuliani
    Cristina Granetto
    Tiziana Pia Latiano
    Silvana Leo
    Paolo Tralongo
    Maria Elena Stroppolo
    Filippo Venturini
    Salvatore Bianco
    Cancer Chemotherapy and Pharmacology, 2019, 84 : 1089 - 1096
12345